- Home
- EQNR vs ZTS Comparison
EQNR vs ZTS Comparison
Compare EQNR & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EQNR | ZTS |
|---|---|---|
| Founded | 1972 | 1952 |
| Country | Norway | United States |
| Employees | N/A | N/A |
| Industry | Integrated oil Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.2B | 66.2B |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | EQNR | ZTS |
|---|---|---|
| Price | $23.03 | $118.91 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 11 |
| Target Price | $28.20 | ★ $174.60 |
| AVG Volume (30 Days) | 4.0M | ★ 5.0M |
| Earning Date | 10-29-2025 | 11-04-2025 |
| Dividend Yield | ★ 6.49% | 1.69% |
| EPS Growth | N/A | ★ 11.64 |
| EPS | 2.15 | ★ 5.94 |
| Revenue | ★ $107,066,000,000.00 | $9,397,000,000.00 |
| Revenue This Year | $1.64 | $3.11 |
| Revenue Next Year | N/A | $5.14 |
| P/E Ratio | ★ $10.75 | $19.99 |
| Revenue Growth | 2.15 | ★ 2.68 |
| 52 Week Low | $21.41 | $115.25 |
| 52 Week High | $28.27 | $181.85 |
Technical Indicators
Market Signals| Indicator | EQNR | ZTS |
|---|---|---|
| Relative Strength Index (RSI) | 44.76 | 38.87 |
| Support Level | $22.58 | $115.59 |
| Resistance Level | $23.44 | $129.58 |
| Average True Range (ATR) | 0.31 | 3.06 |
| MACD | 0.02 | 0.17 |
| Stochastic Oscillator | 64.26 | 23.09 |
Price Performance
Historical ComparisonAbout EQNR Equinor ASA
Equinor is a Norway-based integrated oil and gas company. It has been publicly listed since 2001, but the government retains a 67% stake. Operating primarily on the Norwegian Continental Shelf, the firm produced 2.1 million barrels of oil equivalent per day in 2024 (52% liquids) and ended 2024 with 6.1 billion barrels of proven reserves (42% liquids). Operations also include offshore wind, solar, oil refineries and natural gas processing, marketing, and trading.
About ZTS Zoetis Inc.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.